GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diaceutics PLC (FRA:7DC) » Definitions » Cash Flow from Discontinued Operations

Diaceutics (FRA:7DC) Cash Flow from Discontinued Operations : €0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Diaceutics Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Diaceutics's cash flow from discontinued operations for the six months ended in Dec. 2024 was €0.00 Mil. It means Diaceutics received €0.00 Mil from the sale of part of business quarterly. Diaceutics's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Diaceutics Cash Flow from Discontinued Operations Historical Data

The historical data trend for Diaceutics's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diaceutics Cash Flow from Discontinued Operations Chart

Diaceutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only - - - - -

Diaceutics Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Diaceutics Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diaceutics Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Diaceutics's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.

Diaceutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Diaceutics PLC (FRA:7DC) » Definitions » Cash Flow from Discontinued Operations
Comparable Companies
LSE:OPT LSE:KOO LSE:RENX LSE:COG LSE:INHC LSE:FDBK LSE:TRLS LSE:IQAI AQSE:DXSP VEEV GEHC ASX:PME TEM DOCS TSE:2413 HQY WAY BTSG HKSE:02587 HNGE
Traded in Other Exchanges
DXRX:UK
Address
Kings Hall Health and Wellbeing Park, Dataworks, First Floor, Building Two, Antrim, Belfast, GBR, BT9 6GW
Website
https://www.diaceutics.com
Diaceutics PLC is a data analytics and implementation services company that services the pharmaceutical industry. It provides the pharma and biotech companies with an end-to-end commercialization solution for the launch of precision medicine, enabled by DXRX The Diagnostic Network. DXRX is the diagnostic commercialization platform designed specifically for precision medicine, integrating multiple pipelines of real-world, real-time diagnostic testing data from a network of labs. These solutions are helping the pharma companies commercialize their precision medicines, enhance their return on investment and ultimately improve patients' lives.

Diaceutics Headlines

No Headlines